ARCTIC FRONT ADVANCE® CARDIAC CRYOABLATION CATHETER
Report
- Report Number
- 3002648230-2024-00131
- Event Type
- Injury
- Date Received
- April 3, 2024
- Date of Event
- January 1, 2023
- Report Date
- April 3, 2024
- Manufacturer
- MEDTRONIC CRYOCATH LP
- Product Code
- OAE
- PMA / PMN Number
- P100010
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS INFORMATION IS BASED ENTIRELY ON JOURNAL LITERATURE. MEDTRONIC WAS MADE AWARE OF THIS EVENT THROUGH A SEARCH OF LITERATURE PUBLICATIONS. OF NOTE, MULTIPLE PATIENTS AND MULTIPLE MANUFACTURERS WERE NOTED IN THE ARTICLE; HOWEVER, A ONE-TO-ONE CORRELATION COULD NOT BE MADE WITH UNIQUE PRODUCT SERIAL/LOT NUMBERS. THE BASELINE GENDER/AGE CHARACTERISTICS IS MALE/67 YEARS OLD. WITHOUT A LOT NUMBER OR DEVICE SERIAL NUMBER, THE MANUFACTURING DATE CANNOT BE DETERMINED. SINCE NO DEVICE ID WAS PROVIDED, IT IS UNKNOWN IF THIS EVENT HAS BEEN PREVIOUSLY REPORTED. REFERENCED ARTICLE: RELATIONSHIP BETWEEN AMIODARONE RESPONSE PRIOR TO ABLATION AND 1-YEAR OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (JCE). 2023; 34:860¿868. DOI: 10.1111/JCE.15845. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
LITERATURE WAS REVIEWED REGARDING AMIODARONE RESPONSE PRIOR TO CRYOBALLOON ABLATION AND OUTCOMES. PATIENTS WERE PUT IN COHORTS BY AM IODARONE FAILURE VERSUS AMIODARONE SUCCESS. THE AUTHORS DESCRIBED PROCEDURAL COMPLICATIONS THAT OCCURRED IN BOTH GROUPS WHICH INCLUDED CARDIAC TAMPONADE, UNKNOWN VASCULAR COMPLICATIONS, ASPIRATION PNEUMONIA, AND PULMONARY EMBOLISM. THE STATUS OF THE CATHETERS IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1448115 | ARCTIC FRONT ADVANCE® CARDIAC CRYOABLATION CATHETER | CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION | OAE | MEDTRONIC CRYOCATH LP | 2AF284 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Male | Life Threatening |